\u2018Up Close With\u2019 Juan Carlos Arag\u00f3n<\/a><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"June 21, 2022 By John Sailer, Editor-in-Chief, Review of Myopia Management GILBERT, Ariz. \u2014 It\u2019s clear to anyone involved with myopia management that CooperVision has aligned itself to offer most of the treatments available to slow the progression of axial length growth in children. \u201cOf the four ways to intervene, we cover three of them,\u201d Juan Carlos Arag\u00f3n, president of CooperVision Specialty EyeCare, told Review of Myopia Management during a recent tour of one of its Centers of Excellence, the Paragon CRT manufacturing facility in Gilbert, Arizona. The three myopia management interventions to which he referred are orthokeratology (such as Paragon CRT), dual focus contact lenses (MiSight 1 day), and spectacle lenses (SightGlass Diffusion Optics Technology). While these treatments are offered under the overall corporate CooperVision umbrella, Dr. Arag\u00f3n\u2019s CooperVision Specialty EyeCare business unit is specifically focused on specialty contact lenses such as orthokeratology and scleral lenses. Specializing in Specialty EyeCare \u201cSpecialty is not just the products,\u201d said Dr. Arag\u00f3n. \u201cOur people are special; our doctors are special. We\u2019ve built the broadest and deepest portfolio of specialty lenses.\u201d Over the past few years, he and his team have strategically acquired a group of specialty lens companies to build an entirely new business unit within CooperVision. \u201cIn 2017, we decided to build a separate business unit with a stand-alone management team absolutely focused on what we are doing,\u201d said Dr. Arag\u00f3n. In August of 2017, this CooperVision business unit acquired Procornea in the Netherlands, which had the license to sell the DreamLite orthokeratology lens in China. This was followed by the deal to acquire Paragon, which occurred in December 2017. Again, this was because of its license to sell in China, in this case the Paragon CRT orthokeratology lens. The following year, the acquisition of GP Specialists in August 2020 brought CooperVision Specialty EyeCare its third distributor in China. Because of the incidence of myopia there and the prevalence of orthokeratology to treat it, China is the company\u2019s largest market. Of course, other important markets are the U.S. and Canada in North America, where there is also widespread availability of Paragon CRT and GP Specialists brands. Europe, the Middle East, and Africa are other priorities for CooperVision Specialty EyeCare. London-based No7 Contact Lenses was acquired in April 2021, and most recently, CooperVision acquired EnsEyes in Denmark, a leader in specialty contact lenses in the Nordic region of Europe. In […]<\/p>\n","protected":false},"author":334,"featured_media":43491,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1733],"tags":[3795,3794,460,2207,2684,3759,3799,1857,3798,1952,1846,3797,3796,2417,3788,1891,2878,452,698,1067,2315,1584,3793,111,1409,2424,2204,1465,3800,2205,3792,1947],"yoast_head":"\n
CooperVision Specialty EyeCare Becomes One Stop for Orthokeratology - Review of Myopia Management<\/title>\n \n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n \n \n \n\t \n\t \n\t \n